GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Total Equity

Hwail Pharm Co (XKRX:061250) Total Equity : ₩175,609 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Total Equity?

Hwail Pharm Co's total equity for the quarter that ended in Mar. 2024 was ₩175,609 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Hwail Pharm Co Total Equity Historical Data

The historical data trend for Hwail Pharm Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Total Equity Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119,430.64 156,860.27 181,657.73 175,573.36 174,453.64

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176,843.20 177,616.31 176,468.77 174,453.64 175,609.29

Hwail Pharm Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hwail Pharm Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=186001.476-11547.841
=174,454

Hwail Pharm Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=186723.697-11114.409
=175,609

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hwail Pharm Co Total Equity Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hwail Pharm Co (XKRX:061250) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Total Equity
Comparable Companies
XKRX:006620 XKRX:003120 XKRX:002210 XKRX:389470 XKRX:002620 XKRX:176750 XKRX:214390 XKRX:054670 XKRX:023910 XKRX:330350 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Website
http://www.hwail.com
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines